

Diagnostic Toolkit Aims to Improve Response to Marburg Virus Cases
November 11, 2024
Viral hemorrhagic fevers (VHF) such as Marburg virus disease have recently gained attention due to outbreaks in various parts of the world. Recently, over 60 confirmed cases of Marburg have been reported in Rwanda. Although the risk of Marburg virus

New Diagnostic Test Promises Same-Day Detection of Leptomeningeal Disease
November 1, 2024
UCLA researchers are pioneering a groundbreaking diagnostic test aimed at achieving same-day detection of leptomeningeal disease (LMD), a serious complication that occurs when cancer spreads to the central nervous system. This rapid testing could prove crucial for patients facing dire

Blood Test Identifies Preeclampsia Risk in Laboring Women
October 31, 2024
A groundbreaking blood test may enable doctors to identify laboring women at risk for preeclampsia—a leading cause of maternal mortality—according to research presented at the ANESTHESIOLOGY® 2024 annual meeting. The Centers for Disease Control and Prevention (CDC) reports that between

New Grant to Develop Rapid Biosensors for African
October 30, 2024
Foreign animal diseases pose a significant threat to global swine production, with severe economic consequences. Researchers at the University of Illinois Urbana-Champaign have secured a three-year, $650,000 grant from the U.S. Department of Agriculture (USDA) to create sensitive, rapid, low-cost,

WHO Approves First Mpox In Vitro Diagnostic Test for Emergency Use
October 23, 2024
The World Health Organization (WHO) has made a significant advancement in global health by listing the Alinity m MPXV assay, manufactured by Abbott Molecular Inc., as the first mpox in vitro diagnostic (IVD) test under its Emergency Use Listing (EUL)

MP Biomedicals Launches Advanced Diagnostic Kits for Gastrointestinal Diseases
October 17, 2024
MP Biomedicals is proud to announce the launch of its latest line of advanced in vitro diagnostic kits, designed to enhance the detection of gastrointestinal diseases. This new range of immunochromatographic-based qualitative rapid tests expands our portfolio of infectious disease

Study Reveals Individual Differences in Fasting-Induced Ketosis and Its Health Benefits
October 16, 2024
Context: A recent study published in the journal Nutrients sheds light on the dynamics of fasting-induced ketosis, emphasizing its potential as a non-pharmacological intervention for chronic disease prevention and management. Long-term fasting has been shown to normalize glucose and lipid

Innovative Diagnostic Tests Provide Sustainable Solutions to Plastic Pollution Crisis
October 15, 2024
The escalating global plastic pollution crisis, exacerbated by the COVID-19 pandemic’s surge in single-use diagnostic tests, is driving businesses and researchers to pioneer more sustainable rapid diagnostic solutions. As the world seeks to mitigate plastic waste, new advancements in biodegradable

Here’s what you need to know about rabies 2
July 2, 2024
Prevention Vaccinating dogs Vaccinating dogs, including puppies, through mass dog vaccination programs is the most cost-effective strategy for preventing rabies in people because it stops the transmission at its source. Culling free roaming dogs is not effective in controlling rabies.

Here’s what you need to know about rabies 1
July 1, 2024
Key facts Overview Dog-mediated rabies Rabies is a vaccine-preventable, zoonotic, viral disease affecting the central nervous system. In up to 99% of the human rabies cases, dogs are responsible for virus transmission. Children between the age of 5 and 14

Canadian study highlights need for equity for people with HIV in kidney transplantation
June 29, 2024
People with HIV have a higher risk of end-stage kidney disease than the rest of the population. A study which compared the Danish national HIV cohort to the Danish population found that the risk of end-stage kidney disease requiring dialysis was at

CDC Reports Second Human Case of H5 Bird Flu Tied to Dairy Cow Outbreak
June 28, 2024
May 22, 2024 – A human case of highly pathogenic avian influenza (HPAI) A(H5) (“H5 bird flu”) virus infection in the United States has been identified in the state of Michigan. This is the second case associated with an ongoing multistate outbreak of









